These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 16098035

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antimicrobial efficacy of granulysin-derived synthetic peptides in acne vulgaris.
    Lim HS, Chun SM, Soung MG, Kim J, Kim SJ.
    Int J Dermatol; 2015 Jul; 54(7):853-62. PubMed ID: 25601314
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.
    Popovic S, Urbán E, Lukic M, Conlon JM.
    Peptides; 2012 Apr; 34(2):275-82. PubMed ID: 22374306
    [Abstract] [Full Text] [Related]

  • 5. Pentobra: A Potent Antibiotic with Multiple Layers of Selective Antimicrobial Mechanisms against Propionibacterium Acnes.
    Schmidt NW, Agak GW, Deshayes S, Yu Y, Blacker A, Champer J, Xian W, Kasko AM, Kim J, Wong GCL.
    J Invest Dermatol; 2015 Jun; 135(6):1581-1589. PubMed ID: 25668237
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The therapeutic effect of tanshinone IIA on Propionibacterium acnes-induced inflammation in vitro.
    Li Y, Zhou Y.
    Dermatol Ther; 2018 Nov; 31(6):e12716. PubMed ID: 30246913
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibitory effect of the antimicrobial peptide BLP-7 against Propionibacterium acnes and its anti-inflammatory effect on acne vulgaris.
    Wu Y, Qiang Y, Cao K, Zhang W, Zhang G.
    Toxicon; 2020 Sep; 184():109-115. PubMed ID: 32540219
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.
    Nakatsuji T, Kao MC, Fang JY, Zouboulis CC, Zhang L, Gallo RL, Huang CM.
    J Invest Dermatol; 2009 Oct; 129(10):2480-8. PubMed ID: 19387482
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Short lipopeptides specifically inhibit the growth of Propionibacterium acnes with a dual antibacterial and anti-inflammatory action.
    Yang G, Wang J, Lu S, Chen Z, Fan S, Chen D, Xue H, Shi W, He J.
    Br J Pharmacol; 2019 Jul; 176(13):2321-2335. PubMed ID: 30927447
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid.
    Huang WC, Tsai TH, Chuang LT, Li YY, Zouboulis CC, Tsai PJ.
    J Dermatol Sci; 2014 Mar; 73(3):232-40. PubMed ID: 24284257
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CBT-SL5, a bacteriocin from Enterococcus faecalis, suppresses the expression of interleukin-8 induced by Propionibacterium acnes in cultured human keratinocytes.
    Lee YJ, Choi HJ, Kang TW, Kim HO, Chung MJ, Park YM.
    J Microbiol Biotechnol; 2008 Jul; 18(7):1308-16. PubMed ID: 18667861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.